Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goldenberg

Showing results (771-780 of 968) with videos related to

Pageof 97
Sort By:
Cancer|May 1, 1999
Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinomaM E Juweid, G Hajjar, L C Swayne, et al.
Rheumatology (Oxford, England)|November 26, 2013
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006Vibeke Strand, Michelle Petri, Kenneth Kalunian, et al.
Cancer Research|November 1, 1992
Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodiesR D Blumenthal, R M Sharkey, L Haywood, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2009
Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabineHabibe Karacay, Robert M Sharkey, David V Gold, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
In vitro autoradiography of carcinoembryonic antigen in tissue from patients with colorectal cancer using multifunctional antibody TF2 and (67/68Ga)-labeled haptens by pretargetingHåkan Hall, Irina Velikyan, Elisabeth Blom, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 25, 2003
Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphomaErnst J Postema, Cathelijne Frielink, Wim J G Oyen, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 26, 2017
The mast cell-B cell axis in lung vascular remodeling and pulmonary hypertensionSiegfried Breitling, Zhang Hui, Diana Zabini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1997
Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodiesT M Behr, R M Sharkey, M E Juweid, et al.
Cancer Research|February 1, 1990
Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigensR M Sharkey, D V Gold, R Aninipot, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 15, 2020
Endothelial HMGB1 Is a Critical Regulator of LDL Transcytosis via an SREBP2-SR-BI AxisSiavash Ghaffari, Erika Jang, Farnoosh Naderinabi, et al.
Pageof 97

Showing results (771-780 of 968) with videos related to

Sort By:
Pageof 97
Cancer|May 1, 1999
Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinomaM E Juweid, G Hajjar, L C Swayne, et al.
Rheumatology (Oxford, England)|November 26, 2013
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006Vibeke Strand, Michelle Petri, Kenneth Kalunian, et al.
Cancer Research|November 1, 1992
Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodiesR D Blumenthal, R M Sharkey, L Haywood, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2009
Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabineHabibe Karacay, Robert M Sharkey, David V Gold, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
In vitro autoradiography of carcinoembryonic antigen in tissue from patients with colorectal cancer using multifunctional antibody TF2 and (67/68Ga)-labeled haptens by pretargetingHåkan Hall, Irina Velikyan, Elisabeth Blom, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 25, 2003
Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphomaErnst J Postema, Cathelijne Frielink, Wim J G Oyen, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 26, 2017
The mast cell-B cell axis in lung vascular remodeling and pulmonary hypertensionSiegfried Breitling, Zhang Hui, Diana Zabini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1997
Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodiesT M Behr, R M Sharkey, M E Juweid, et al.
Cancer Research|February 1, 1990
Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigensR M Sharkey, D V Gold, R Aninipot, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 15, 2020
Endothelial HMGB1 Is a Critical Regulator of LDL Transcytosis via an SREBP2-SR-BI AxisSiavash Ghaffari, Erika Jang, Farnoosh Naderinabi, et al.
Pageof 97